Ovarian Cancer: Frontline Therapy - Episode 5

Selecting a PARP Inhibitor for Front Line Maintenance in Advance Ovarian Cancer

Dr. Rebecca Previs discusses the role of PARP inhibitors in first line maintenance therapy in advanced ovarian cancer.